Perrigo Research and Development Expenses 2010-2024 | PRGO
Perrigo research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Perrigo Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $123 |
| 2022 | $123 |
| 2021 | $122 |
| 2020 | $122 |
| 2019 | $119 |
| 2018 | $219 |
| 2017 | $168 |
| 2016 | $184 |
| 2015 | $88 |
| 2015 | $188 |
| 2014 | $153 |
| 2013 | $115 |
| 2012 | $106 |
| 2011 | $89 |
| 2010 | $84 |
| 2009 | $77 |
| Perrigo Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | $29 |
| 2023-12-31 | $30 |
| 2023-09-30 | $30 |
| 2023-06-30 | $32 |
| 2023-03-31 | $31 |
| 2022-12-31 | $33 |
| 2022-09-30 | $30 |
| 2022-06-30 | $32 |
| 2022-03-31 | $29 |
| 2021-12-31 | $30 |
| 2021-09-30 | $28 |
| 2021-06-30 | $33 |
| 2021-03-31 | $31 |
| 2020-12-31 | $33 |
| 2020-09-30 | $30 |
| 2020-06-30 | $30 |
| 2020-03-31 | $28 |
| 2019-12-31 | $-9 |
| 2019-09-30 | $44 |
| 2019-06-30 | $44 |
| 2019-03-31 | $40 |
| 2018-12-31 | $45 |
| 2018-09-30 | $44 |
| 2018-06-30 | $92 |
| 2018-03-31 | $38 |
| 2017-12-31 | $47 |
| 2017-09-30 | $38 |
| 2017-06-30 | $43 |
| 2017-03-31 | $40 |
| 2016-12-31 | $42 |
| 2016-09-30 | $50 |
| 2016-06-30 | $47 |
| 2016-03-31 | $45 |
| 2015-12-31 | $-51 |
| 2015-09-30 | $42 |
| 2015-06-30 | $63 |
| 2015-03-31 | $35 |
| 2014-12-31 | $53 |
| 2014-09-30 | $37 |
| 2014-06-30 | |
| 2014-03-31 | $45 |
| 2013-12-31 | $38 |
| 2013-09-30 | $32 |
| 2013-06-30 | |
| 2013-03-31 | $29 |
| 2012-12-31 | $28 |
| 2012-09-30 | $27 |
| 2012-06-30 | |
| 2012-03-31 | $28 |
| 2011-12-31 | $31 |
| 2011-09-30 | $20 |
| 2011-06-30 | |
| 2011-03-31 | $24 |
| 2010-12-31 | $25 |
| 2010-09-30 | $18 |
| 2010-06-30 | |
| 2010-03-31 | $18 |
| 2009-12-31 | $21 |
| 2009-09-30 | $19 |
| 2009-06-30 | |
| 2009-03-31 | $18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.241B | $4.656B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.557B | 23.90 |
| Stryker (SYK) | United States | $125.439B | 30.04 |
| Medtronic (MDT) | Ireland | $108.284B | 15.33 |
| Boston Scientific (BSX) | United States | $106.687B | 33.98 |
| EssilorLuxottica (ESLOY) | France | $99.794B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.125B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.397B | 27.30 |
| ResMed (RMD) | United States | $31.274B | 29.36 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.862B | 15.88 |
| Terumo (TRUMY) | Japan | $24.701B | 34.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.145B | 18.70 |
| Baxter (BAX) | United States | $18.217B | 12.95 |
| Insulet (PODD) | United States | $12.294B | 64.55 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.929B | 0.00 |
| Demant (WILYY) | Denmark | $10.100B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.650B | 25.02 |
| BellRing Brands (BRBR) | United States | $7.607B | 35.63 |
| Lantheus Holdings (LNTH) | United States | $5.164B | 12.87 |
| Haemonetics (HAE) | United States | $4.736B | 24.22 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Prestige Consumer Healthcare (PBH) | United States | $3.468B | 16.40 |
| Envista Holdings (NVST) | United States | $3.236B | 13.35 |
| QuidelOrtho (QDEL) | United States | $2.854B | 15.87 |
| TG Therapeutics (TGTX) | United States | $2.646B | 74.43 |
| Neogen (NEOG) | United States | $2.610B | 25.10 |
| Green Thumb Industries (GTBIF) | United States | $2.604B | 51.58 |
| ICU Medical (ICUI) | United States | $2.451B | 21.63 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.843B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.686B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.683B | 49.34 |
| InMode (INMD) | Israel | $1.537B | 8.17 |
| Owens & Minor (OMI) | United States | $1.386B | 12.08 |
| AdaptHealth (AHCO) | United States | $1.288B | 9.59 |
| Warby Parker (WRBY) | United States | $1.233B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.167B | 37.25 |
| AtriCure (ATRC) | United States | $0.985B | 0.00 |
| MacroGenics (MGNX) | United States | $0.917B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.915B | 0.00 |
| Evolus (EOLS) | United States | $0.830B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.813B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.710B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.696B | 14.81 |
| VAREX IMAGING (VREX) | United States | $0.644B | 15.14 |
| Quanterix (QTRX) | United States | $0.631B | 0.00 |
| PetIQ (PETQ) | United States | $0.519B | 16.97 |
| Valneva SE (VALN) | France | $0.504B | 0.00 |
| Jin Medical (ZJYL) | China | $0.494B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
| Biote (BTMD) | United States | $0.452B | 8.67 |
| Surmodics (SRDX) | United States | $0.450B | 28.20 |
| ZimVie (ZIMV) | United States | $0.419B | 35.77 |
| OraSure Technologies (OSUR) | United States | $0.406B | 12.64 |
| Aurora Cannabis (ACB) | Canada | $0.350B | 0.00 |
| Cerus (CERS) | United States | $0.348B | 0.00 |
| Zynex (ZYXI) | United States | $0.341B | 46.65 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.282B | 27.96 |
| TriSalus Life Sciences (TLSI) | United States | $0.258B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.248B | 15.33 |
| Veru (VERU) | United States | $0.209B | 0.00 |
| Omeros (OMER) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.185B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.182B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.173B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.169B | 0.00 |
| InterCure (INCR) | Israel | $0.151B | 25.54 |
| Eagleford Energy (GRUSF) | United States | $0.140B | 70.42 |
| Jushi Holdings (JUSHF) | United States | $0.137B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 22.00 |
| Cellectar Biosciences (CLRB) | United States | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.111B | 9.54 |
| MariMed (MRMD) | United States | $0.109B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.101B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 0.00 |
| Brainsway (BWAY) | Israel | $0.095B | 0.00 |
| Chimerix (CMRX) | United States | $0.087B | 0.00 |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
| Zevia PBC (ZVIA) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.42 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.73 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |